Deferasirox for managing transfusional iron overload in people with sickle cell disease
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To evaluate the effectiveness and safety of oral deferasirox for management of transfusional iron overload in people with SCD.